Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Huri Ozdogan

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
Presse Medicale (Paris, France : 1983)|January 29, 2019
Familial Mediterranean FeverHuri Ozdogan, Serdal Ugurlu
Expert Review of Clinical Immunology|April 1, 2017
Canakinumab for the treatment of familial Mediterranean feverHuri Ozdogan, Serdal Ugurlu
Current Drug Targets. Inflammation and Allergy|February 22, 2005
Molecular and genetic characteristics of hereditary autoinflammatory diseasesMehmet Tunca, Huri Ozdogan
Clinical and Experimental Rheumatology|November 8, 2019
Familial Mediterranean fever: misdiagnosis and diagnostic delay in TurkeyMustafa Erdogan, Serdal Ugurlu, Huri Ozdogan, et al.
Internal and Emergency Medicine|January 21, 2022
Late-onset familial mediterranean fever: single-center experience and literature reviewOkan Aydin, Bugra Han Egeli, Huri Ozdogan, et al.
Orphanet Journal of Rare Diseases|June 1, 2017
Tocilizumab in the treatment of twelve cases with aa amyloidosis secondary to familial mediterranean feverSerdal Ugurlu, Aysa Hacioglu, Yasaman Adibnia, et al.
Clinical and Experimental Rheumatology|October 5, 2011
The frequency of familial Mediterranean fever in an emergency unitSeval Masatlioglu, Ender Dulundu, Feride Gogus, et al.
Immunological Investigations|April 24, 2020
Soluble TREM-1 Levels in Familial Mediterranean Fever Related AA-AmyloidosisSerdal Ugurlu, Bugra Han Egeli, Ibrahim Murat Bolayirli, et al.
Rheumatology (Oxford, England)|June 20, 2020
Safety and efficacy of anti-interleukin-1 treatment in 40 patients, followed in a single centre, with AA amyloidosis secondary to familial Mediterranean feverSerdal Ugurlu, Bilgesu Ergezen, Bugra Han Egeli, et al.
Clinical and Experimental Rheumatology|November 18, 2017
Other autoinflammatory disease genes in an FMF-prevalent population: a homozygous MVK mutation and a novel heterozygous TNFRSF1A mutation in two different Turkish families with clinical FMFİlker Karacan, Serdal Uğurlu, Aslıhan Tolun, et al.
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
Presse Medicale (Paris, France : 1983)|January 29, 2019
Familial Mediterranean FeverHuri Ozdogan, Serdal Ugurlu
Expert Review of Clinical Immunology|April 1, 2017
Canakinumab for the treatment of familial Mediterranean feverHuri Ozdogan, Serdal Ugurlu
Current Drug Targets. Inflammation and Allergy|February 22, 2005
Molecular and genetic characteristics of hereditary autoinflammatory diseasesMehmet Tunca, Huri Ozdogan
Clinical and Experimental Rheumatology|November 8, 2019
Familial Mediterranean fever: misdiagnosis and diagnostic delay in TurkeyMustafa Erdogan, Serdal Ugurlu, Huri Ozdogan, et al.
Internal and Emergency Medicine|January 21, 2022
Late-onset familial mediterranean fever: single-center experience and literature reviewOkan Aydin, Bugra Han Egeli, Huri Ozdogan, et al.
Orphanet Journal of Rare Diseases|June 1, 2017
Tocilizumab in the treatment of twelve cases with aa amyloidosis secondary to familial mediterranean feverSerdal Ugurlu, Aysa Hacioglu, Yasaman Adibnia, et al.
Clinical and Experimental Rheumatology|October 5, 2011
The frequency of familial Mediterranean fever in an emergency unitSeval Masatlioglu, Ender Dulundu, Feride Gogus, et al.
Immunological Investigations|April 24, 2020
Soluble TREM-1 Levels in Familial Mediterranean Fever Related AA-AmyloidosisSerdal Ugurlu, Bugra Han Egeli, Ibrahim Murat Bolayirli, et al.
Rheumatology (Oxford, England)|June 20, 2020
Safety and efficacy of anti-interleukin-1 treatment in 40 patients, followed in a single centre, with AA amyloidosis secondary to familial Mediterranean feverSerdal Ugurlu, Bilgesu Ergezen, Bugra Han Egeli, et al.
Clinical and Experimental Rheumatology|November 18, 2017
Other autoinflammatory disease genes in an FMF-prevalent population: a homozygous MVK mutation and a novel heterozygous TNFRSF1A mutation in two different Turkish families with clinical FMFİlker Karacan, Serdal Uğurlu, Aslıhan Tolun, et al.
Pageof 5